Print

Unusual Gerresheimer's closure system for pharmaceutical products Rewolucyjne zamknięcie dla opakowań farmaceutycznych

Unusual Gerresheimer's closure system for pharmaceutical products
Increased safety - and in addition increased economy through the entire process chain: with these qualities an innovative closure system for pharmaceutical products totally convinced the jury for the 2007 German Packaging Award. This internationally prestigious prize was awarded to the new type of desiccant closures for tablet containers which Gerresheimer has developed under the Duma trademark.

Gerresheimer is the first company in the world to produce the multi-function plastic products completely in one connected process - together with the integrated desiccant elements. The result is regarded as a pioneering innovation: for the pharma industry it also facilitates fulfilment of the prescribed registration requirements.

Tablets and pills are highly sensitive to moisture. In high-quality tablet containers the desiccant elements which provide protection against the effects of moisture have for some time been incorporated directly in the closure.

Gerresheimer's closure system for pharmaceutical products

Under the standards which have so far applied, however, the desiccant element which absorbs moisture was produced separately from the actual closure and incorporated only later as an outsourced component.

The pharmaceutical plastic experts in Gerresheimer`s plant in Vaerloese in Denmark disliked this circuitous approach not only for logistical but also economic reasons. - Our principle is to offer the pharma industry everything from a single source as far as possible - comments Burkhard Lingenberg, Director of Corporate PR and Marketing for the Gerresheimer Group. - This ingenious innovation once again demonstrates how important that is. It optimises a whole product category and simplifies procedures right through to the registration process.

Gerresheimer`s Plastic Packaging Division conceived a fully integrated production method which was met with open arms by the pharma industry.